FDA Approval Activities for this Drug
Daunorubicin Hydrochloride for Injection, 5 mg/ml, 4ml vials, Bedford NDA 50-731 1/30/98 1/7/99
Daunorubicin Hydrochloride for Injection, 20 mg (base)/single dose vial, Bigmar ANDA 65-000 5/25/99 5/26/99
Daunorubicin Hydrochloride for Injection, 20 mg (base)/single dose vial, Gensia Sicor ANDA 64-212 6/23/98 6/26/98
Daunorubicin Hydrochloride Injection, 5 mg (base)/mL, (packaged in 20 mg (base)/4 mL and 50 mg (base)/10 mL single-dose vials), Gensia Sicor ANDA 65-035 1/24/00 2/4/00
Daunorubicin Hydrochloride Injection, 5 mg (base)/mL, (packaged in 20 mg (base)/4 mL single-dose vials), SuperGen, ANDA 65-034 11/20/01 10/10/02
DaunoXome (daunorubicin citrate liposome injection), Gilead Sciences, NDA 50-704/S-008 DAUNORUBICIN CITRATE Injectable, Liposomal; Injection 2MG BASE/ML DAUNOXOME GILEAD
064103 DAUNORUBICIN HYDROCHLORIDE Injection 20MG BASE/VIAL CERUBIDINE Bedford 050731 DAUNORUBICIN HYDROCHLORIDE Injection 5MG BASE/ML DAUNORUBICIN HCL Bedford 065000 DAUNORUBICIN HYDROCHLORIDE Injection 20MG BASE/VIAL DAUNORUBICIN HCL BIGMAR
064212 DAUNORUBICIN HYDROCHLORIDE Injection 20MG BASE/VIAL DAUNORUBICIN HCL Gensia Sicor 064212 DAUNORUBICIN HYDROCHLORIDE Injection 50MG BASE/VIAL DAUNORUBICIN HCL Gensia Sicor 065035 DAUNORUBICIN HYDROCHLORIDE Injection 5MG BASE/ML DAUNORUBICIN HCL Gensia Sicor 065034 DAUNORUBICIN HYDROCHLORIDE Injection 5MG BASE/VIAL DAUNORUBICIN HCL SUPERGEN